
How Pharma Companies Are Navigating the New Clinical Trial Landscape: A Mixed Response
In the wake of recent regulatory changes regarding diversity in clinical trials, pharmaceutical companies have begun revealing their strategic positions. After previously exploring the various paths companies could take –